Literature DB >> 4735946

O-methylation of apomorphine and the metabolic prolongation of apomorphine-induced stereotyped behaviour.

K Missala, S Lal, T L Sourkes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4735946     DOI: 10.1016/0014-2999(73)90183-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  7 in total

1.  Behavioral effects of apomorphine and diisobutyrylapomorphine in the mouse.

Authors:  R J Baldessarini; N S Kula; K G Walton
Journal:  Psychopharmacology (Berl)       Date:  1977-06-06       Impact factor: 4.530

Review 2.  Pharmacokinetic-pharmacodynamic relationships of apomorphine in patients with Parkinson's disease.

Authors:  C Neef; T van Laar
Journal:  Clin Pharmacokinet       Date:  1999-09       Impact factor: 6.447

3.  Hypothalamic-pituitary dopaminergic function in hepatic failure in man.

Authors:  S Lal; M Oravec; A Aronoff; M E Kiely; H Guyda; S Solomon; N P Nair
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

4.  Monoamine oxidase and cerebral uptake of dopaminergic drugs.

Authors:  G C Cotzias; L C Tang; J Z Ginos
Journal:  Proc Natl Acad Sci U S A       Date:  1974-07       Impact factor: 11.205

5.  Concerted actions of the catechol O-methyltransferase and the cytosolic sulfotransferase SULT1A3 in the metabolism of catecholic drugs.

Authors:  Katsuhisa Kurogi; Adnan Alazizi; Ming-Yih Liu; Yoichi Sakakibara; Masahito Suiko; Takuya Sugahara; Ming-Cheh Liu
Journal:  Biochem Pharmacol       Date:  2012-08-16       Impact factor: 5.858

6.  Brain and serum concentrations of dopamine analogues after peripheral administration to rats.

Authors:  M G Feenstra; J W Homan; R Everts; H Rollema; A S Horn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-06       Impact factor: 3.000

Review 7.  Challenges and trends in apomorphine drug delivery systems for the treatment of Parkinson's disease.

Authors:  Nrupa Borkar; Huiling Mu; René Holm
Journal:  Asian J Pharm Sci       Date:  2017-12-06       Impact factor: 6.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.